[1]
|
佚名. 2019年全国细菌耐药监测报告[R]. 北京: 国家卫生健康委合理用药专家委员会, 2020.
|
[2]
|
胡付品, 郭燕, 朱德妹, 汪复, 蒋晓飞, 徐英春, 等. 2016年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志, 2017, 17(5): 481-491.
|
[3]
|
El-Halfawy, O.M. and Valvano, M.A. (2015) Antimicrobial Heteroresistance: An Emerging Field in Need of Clarity. Clinical Microbiology Reviews, 28, 191-207. https://doi.org/10.1128/CMR.00058-14
|
[4]
|
Alam, M.R., Donabedian, S., Brown, W., Gordon, J., Chow, J.W., Zervos, M.J., et al. (2001) Heteroresistance to Vancomycin in Enterococcus faecium. Journal of Clinical Microbiology, 39, 3379-3381.
https://doi.org/10.1128/JCM.39.9.3379-3381.2001
|
[5]
|
Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T. and Tenover, F.C. (1997) Methicillin-Resistant Staphylococcus aureus Clinical Strain with Reduced Vancomycin Susceptibility. Journal of Antimicrobial Chemotherapy, 40, 135-136.
https://doi.org/10.1093/jac/40.1.135
|
[6]
|
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., et al. (1997) Dissemination in Japanese Hospitals of Strains of Staphylococcus aureus Heterogeneously Resistant to Vancomycin. Lancet, 350, 1670-1673.
https://doi.org/10.1016/S0140-6736(97)07324-8
|
[7]
|
Pournaras, S., Ikonomidis, A., Markogiannakis, A., Spanakis, N., Maniatis, A.N. and Tsakris, A. (2007) Characterization of Clinical Isolates of Pseudomonas aeruginosa Heterogeneously Resistant to Carbapenems. Journal of Medical Microbiology, 56, 66-70. https://doi.org/10.1099/jmm.0.46816-0
|
[8]
|
Pournaras, S., Ikonomidis, A., Markogiannakis, A., Maniatis, A.N., Tsakris, A., et al. (2005) Heteroresistance to Carbapenems in Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy, 55, 1055-1056.
https://doi.org/10.1093/jac/dki115
|
[9]
|
Sancak, B., Yagci, S., Gür, D., Gülay, Z., Ogunc, D., Söyletir, G., et al. (2013) Vancomycin and Daptomycin Minimum Inhibitory Concentration Distribution and Occurrence of Heteroresistance among Methicillin-Resistant Staphylococcus aureus Blood Isolates in Turkey. BMC Infectious Diseases, 13, Article No. 583.
https://doi.org/10.1186/1471-2334-13-583
|
[10]
|
Kirby, A., Mohandas, K., Broughton, C., Neal, T.J., Smith, G.W., Pai, P., et al. (2009) In Vivo Development of Heterogeneous Glycopeptide-Intermediate Staphylococcus aureus (hGISA), GISA and Daptomycin Resistance in a Patient with Meticillin-Resistant S. aureus Endocarditis. Journal of Medical Microbiology, 58, 376-380.
https://doi.org/10.1099/jmm.0.006486-0
|
[11]
|
Savini, V., Catavitello, C., Talia, M., Febbo, F., Balbinot, A., Pompilio, A., et al. (2009) Misidentification of Ampicillin-Sulbactam Heteroresistance in Acinetobacter baumannii Strains from ICU Patient. Journal of Infection, 58, 316-317. https://doi.org/10.1016/j.jinf.2009.02.001
|
[12]
|
李玮, 王凯亮, 熊祝嘉, 李俊秋, 崔翠莲. 353株铜绿假单胞菌医院感染的临床分布与耐药性分析[J]. 中国实验诊断学, 2015(7): 1107-1109.
|
[13]
|
余建洪, 李敏, 何小平, 陈喻, 张肃川, 张小丹. 2016-2018年某医院耐碳青霉烯类铜绿假单胞菌的耐药性及临床特征分析[J]. 安徽医药, 2021, 25(5): 931-934.
|
[14]
|
莫善颖, 李梦薇, 韦柳华, 等. 铜绿假单胞菌的临床分布及耐药性分析[J]. 中华医院感染学杂志, 2011, 23(22): 5553-5555.
|
[15]
|
冯娜娜, 李华茵, 宋元林, 王琴, 周春妹, 谢红梅. 医院铜绿假单胞菌性肺炎对抗菌药物耐药性及死亡率相关性研究[J]. 中华医院感染学杂志, 2012, 22(13): 2917-2919+2957.
|
[16]
|
Sharma, K.K. and Kalawat, U. (2010) Emerging Infections: Shewanella—A Series of Five Cases. Journal of Laboratory Physicians, 2, 61-65. https://doi.org/10.4103/0974-2727.72150
|
[17]
|
Iyer, R. and Hittinahalli, V. (2008) Modified PAP Method to Detect Heteroresistance to Vancomycin among Methicillin Resistant Staphylococcus aureus Isolates at a Tertiary Care Hospital. Indian Journal of Medical Microbiology, 26, 176-179. https://doi.org/10.1016/S0255-0857(21)01939-3
|
[18]
|
Hu, Q., Yu, Y., Gu, D., Xie, L., Chen, X., Xu, N., et al. (2019) Detection of “Hidden” Antimicrobial Drug Resistance. ACS Infectious Diseases, 5, 1252-1563. https://doi.org/10.1021/acsinfecdis.9b00132
|
[19]
|
Jia, X., Ma, W., He, J., Tian, X., Liu, H., Zou, H., et al. (2019) Heteroresistance to Cefepime in Pseudomonas aeruginosa Bacteremia. International Journal of Antimicrobial Agents, 55, Article No. 105832.
https://doi.org/10.1016/j.ijantimicag.2019.10.013
|
[20]
|
Alexandros, I., Athanassios, T., Maria, K., Spanakis, N., Maniatis, A.N. and Pournaras, S. (2010) Efflux System Overexpression and Decreased OprD Contribute to the Carbapenem Heterogeneity in Pseudomonas aeruginosa. FEMS Microbiology Letters, 279, 36-39. https://doi.org/10.1111/j.1574-6968.2007.00997.x
|
[21]
|
Mei, S., Gao, Y., Zhu, C., Dong, C. and Chen, Y. (2014) Research of the Heteroresistance of Pseudomonas aeruginosa to Imipenem. International Journal of Clinical & Experimental Medicine, 8, 6129-6132.
|
[22]
|
Xu, Y., Zheng, X., Zeng, W., Chen, T., Liao, W., Qian, J., et al. (2020) Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa. Infection and Drug Resistance, 13, 1419-1428.
https://doi.org/10.2147/IDR.S249475
|
[23]
|
He, J., Jia, X., Yang, S., Xu, X., Sun, K., Li, C., et al. (2017) Heteroresistance to Carbapenems in Invasive Pseudomonas aeruginosa Infections. International Journal of Antimicrobial Agents, 51, 413-421.
https://doi.org/10.1016/j.ijantimicag.2017.10.014
|
[24]
|
Oikonomou, O., Panopoulou, M. and Ikonomidis, A. (2011) Investigation of Carbapenem Heteroresistance among Different Sequence Types of Pseudomonas aeruginosa Clinical Isolates Reveals Further Diversity. Journal of Medical Microbiology, 60, 1556-1558. https://doi.org/10.1099/jmm.0.032276-0
|
[25]
|
Spyros, P., Alexandros, I., Evangelia, N., Kantzanou, M., Maniatis, A.N. and Tsakris, A. (2008) Piperacillin/Tazobactam-Heteroresistant Pseudomonas aeruginosa from Urinary Infection, Successfully Treated by Piperacillin/Tazobactam. Journal of Antimicrobial Chemotherapy, 61, 757-758. https://doi.org/10.1093/jac/dkm528
|
[26]
|
Hermes, D.M., Pitt, C.P., Lutz, L., Teixeira, A.B., Ribeiro, V.B., Netto, B., et al. (2013) Evaluation of Heteroresistance to Polymyxin B among Carbapenem-Susceptible and-Resistant Pseudomonas aeruginosa. Journal of Medical Microbiology, 62, 1184-1189. https://doi.org/10.1099/jmm.0.059220-0
|
[27]
|
Lin, J., Xu, C., Fang, R., Cao, J., Zhang, X., Zhao, Y., et al. (2019) Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China. Antimicrobial Agents and Chemotherapy, 63, Article ID: e00556-19. https://doi.org/10.1128/AAC.00556-19
|
[28]
|
Hall, C.W., Hinz, A.J., Gagnon, L., Zhang, L., Nadeau, J.P., Copeland, S., et al. (2018) Pseudomonas aeruginosa Biofilm Antibiotic Resistance Gene ndvB Expression Requires the RpoS Stationary-Phase Sigma Factor. Applied and Environmental Microbiology Journal, 84, Article ID: e02762-17. https://doi.org/10.1128/AEM.02762-17
|
[29]
|
Endimiani, A., Perez, F. and Bonomo, R.A. (2008) Cefepime: A Reappraisal in an Era of Increasing Antimicrobial Resistance. Expert Review of Anti-Infective Therapy, 6, 805-824. https://doi.org/10.1586/14787210.6.6.805
|
[30]
|
Hocquet, D., Nordmann, P. and Garch, F.E. (2006) Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 50, 1347-1351. https://doi.org/10.1128/AAC.50.4.1347-1351.2006
|
[31]
|
Bagge, N., Hentzer, M., Andersen, J.B., Ciofu, O., Givskov, M. and Høiby, N. (2004) Dynamics and Spatial Distribution of Beta-Lactamase Expression in Pseudomonas aeruginosa Biofilms. Antimicrobial Agents and Chemotherapy, 48, 1168-1174. https://doi.org/10.1128/AAC.48.4.1168-1174.2004
|
[32]
|
Balasubramanian, D., Schneper, L., Merighi, M., Smith, R., Narasimhan, G., Lory, S., et al. (2012) The Regulatory Repertoire of Pseudomonas aeruginosa AmpC-Lactamase Regulator AmpR Includes Virulence Genes. PLoS ONE, 7, Article No. e34067. https://doi.org/10.1371/journal.pone.0034067
|
[33]
|
World Health Organization (2020, October 13) Antimicrobial Resistance.
https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
|
[34]
|
Ozturk, I.I., Sirinkaya, E.T., Cakmak, M., Gürgan, M., Ceyhan, D., Panagiotou, N., et al. (2020) Structural and Biological Features of Bismuth(III) Halide Complexes with Heterocyclic Thioamides. Journal of Molecular Structure, 1227, Article ID: 129730. https://doi.org/10.1016/j.molstruc.2020.129730
|
[35]
|
陈婷, 师健友, 戚宝文, 白兰, 周艳平, 段醒妹, 等. N-取代苯基-5-取代苯基-3H-1,2,4-三唑-3-硫酮衍生物的合成及抗菌活性研究[J]. 中国抗生素杂志, 2019, 44(4): 437-449.
|
[36]
|
谭丽, 程优, 柏乐, 王玲, 贺腊姑, 胡敏. 抗菌肽lycosin-I对铜绿假单胞菌临床分离株的体外抗菌活性分析[J]. 临床检验杂志, 2018, 36(4): 253-258.
|
[37]
|
王彩虹, 单志炜, 邓国为, 张耀谋. 新型鹅去氧胆酸衍生物的合成及其抗菌活性[J]. 合成化学, 2019, 27(8): 638-642.
|
[38]
|
叶祥, 周晶, 潘佳, 何菱, 齐庆蓉. 新型氟喹诺酮类衍生物的设计合成及其体外抗菌活性的初探[J]. 华西药学杂志, 2015, 30(1): 1-4.
|
[39]
|
王广成, 何典雄, 刘文超, 彭知云. 新型甲硝唑-苯腙类化合物的设计, 合成及抗菌活性研究[J]. 化学试剂, 2016, 38(7): 602-607.
|
[40]
|
Moustafa, D.A., Wu, A.W., Zamora, D., Daly, S.M., Sturge, C.R., Pybus, C., Geller, B.L., et al. (2021) Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa in Vitro and in Vivo. mBio, 12, Article ID: e02411-20. https://doi.org/10.1128/mBio.02411-20
|